KURA
Kura Oncology Inc
10.90$
-1.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Kura Oncology Inc (KURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -64 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -18 | -25 | -28 | -49 | -55 | -70 | -105 | -110 | -125 | 134 | -64 | |
| – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.1 | 0.2 | 0.6 | 0.8 | 0.8 | 0.8 | -7.5 | |
| – | – | – | – | – | – | 0.0 | 2.3 | 2.1 | 4.5 | 8.7 | 9.4 | 13 | 24 | 26 | 28 | 34 | 37 | |
| – | – | – | – | – | – | 2.2 | 3.3 | 2.3 | 4.4 | 9.2 | 9.4 | 13 | 24 | 26 | – | – | – | |
| – | – | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 1.4 | -0.1 | 2.6 | 4.4 | 0.1 | 6.4 | -3.2 | -3.0 | 7.8 | 286 | 184 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 2.2 | 2.2 | 2.2 | 2.2 | 1.1 | 0.6 | 0.2 | 0.5 | 6.6 | |
| – | – | – | – | – | – | 0.0 | -71 | 12 | -23 | -79 | -46 | -100 | -127 | 33 | 16 | -102 | -13 | |
| – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 98 | 54 | 54 | 132 | 108 | 459 | – | 29 | – | – | – | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 5.0 | 7.5 | -0.6 | -0.6 | -0.3 | -0.3 | -7.9 | 9.4 | 0.0 | 0.0 | – | |
| – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 103 | 7.5 | 54 | 133 | 111 | 469 | -3.4 | 39 | 95 | 154 | 1.8 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 14 | -5.7 | 1.7 | 4.7 | 10 | 300 | -235 | -39 | -14 | 187 | -75 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -18 | -25 | -28 | -49 | -55 | -72 | -106 | -111 | -125 | 134 | -71 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.